(S)-(-)-Carbidopa
Tocris Bioscience | Catalog # 0455
Key Product Details
Description
Product Description
(S)-(-)-Carbidopa is a peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism.
Product Specifications for (S)-(-)-Carbidopa
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 4.52 | 20 |
Preparing Stock Solutions for (S)-(-)-Carbidopa
The following data is based on the product molecular weight 226.23.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 22.10 mL | 110.51 mL | 221.01 mL |
| 1 mM | 4.42 mL | 22.10 mL | 44.20 mL |
| 2 mM | 2.21 mL | 11.05 mL | 22.10 mL |
| 10 mM | 0.44 mL | 2.21 mL | 4.42 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 5 publications citing the usage of this product.
- Kopfhammer L-Dopa infusion experiments in combination with the L-dopa decarboxylase inhibitors benserazide and carb. - L-dopa metabolism and neuroendocrinological effects. Pharmacopsychiatry
- Cheng Carbidopa inhibition of aromatic L-amino acid decarboxylase in rat brain capilliaries. FASEB J.
Product Documents for (S)-(-)-Carbidopa
Product Specific Notices for (S)-(-)-Carbidopa
For research use only
Citations for (S)-(-)-Carbidopa
Customer Reviews for (S)-(-)-Carbidopa (1)
Have you used (S)-(-)-Carbidopa?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanVerified Customer | Posted 08/16/2019Carbidopa acts as a peripheral DDC inhibitor, and carbidopa was used to understand it's effect on brain DDC conversion of levodopa/L-DOPA to dopamine.
There are no reviews that match your criteria.